Letter by Dan et al Regarding Article, “Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with great interest the report by Schneider et al,1 in which they described the efficacy and safety of IN.PACT drug-coated balloon (DCB) to treat femoropopliteal lesions. The patency and freedom from clinically driven target lesion revascularization were better compared with standard percutaneous transluminal angioplasty. Nevertheless, there was a higher rate of death in the DCB group. In a previous publication, patients with below-the-knee lesions treated with IN.PACT DCB …